You are viewing just a glimpse of the 100+ pieces of sophisticated insight and analysis produced by our full-time team of senior financial journalists every day. For full access, check to see if your firm has a license to The Deal Pipeline or login using your existing credentials.
After pricing lower than expected at $10 per share, Greenway Medical Technologies Inc. raised $67 million in its initial public offering and began trading on the New York Stock Exchange Thursday, Feb. 2, under the ticker GWAY. The CEO of the healthcare IT company, Wyche "Tee" Green, explains Greenway's IPO rationale and overarching strategies. Says Green, now is the right time for the company to IPO because "we've experienced tremendous growth." Greenway recently benefited from the Hitech Act, which offers providers financial incentives for converting paperwork into electronic health records. Green says that part of the capital raised from the IPO will be used to make "innovation" acquisitions such as "consumer technology for providers" as well as "technologies that enable us to enter new markets." - Katie Roof
City National Bank tapped Richard Limekiller as a senior vice president and senior portfolio manager in New York. He spent nearly 20 years with U.S. Trust, Bank of America Private Wealth Management. For other updates launch today's Movers & shakers slideshow.